Skip to content
lifestyle.longislandreport.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Opus Genetics, Inc.
Opus Genetics Added to the Russell 3000®, Russell 2000® and Russell Microcap® Indexes
June 26, 2026
Opus Genetics Highlights Five Gene Therapy Programs Targeting Significant Unmet Need in Patients with Inherited Retinal Diseases
June 16, 2026
Opus Genetics to Host Virtual R&D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts
June 2, 2026
Opus Genetics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
May 28, 2026
Opus Genetics to Present at the 2026 Jefferies Global Healthcare Conference
May 27, 2026
Opus Genetics to Participate in Leading Medical Conferences in May 2026
April 27, 2026
Opus Genetics Solidifies Leadership Position in Gene Therapy Development for Inherited Retinal Diseases with Strategic Long-Term Financing by Oberland Capital
April 6, 2026
Opus Genetics Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2026
March 24, 2026
Opus Genetics Announces Financial Results for Full Year 2025 and Provides Corporate Update
March 10, 2026
Opus Genetics to Present at Upcoming Investor Conferences in March 2026
March 3, 2026
1
2
Next Page
→